UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Safety of rituximab therapy during the first trimester of pregnancy: a case history

European journal of haematology, 2004-04, Vol.72 (4), p.292-295

2004

Link zum Volltext

Verfügbarkeit prüfen

1088 DRUG-INDUCED LIVER INJURY DUE TO CHEMOTHERAPEUTIC AGENTS AND OTHER CANCER MEDICATIONS. A POPULATION BASED STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1304-S-1304

2020

Link zum Volltext

Verfügbarkeit prüfen

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

The New England journal of medicine, 2019-12, Vol.381 (26), p.2506-2518

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatotoxicity associated with ribociclib among breast cancer patients

Acta oncologica, 2021-02, Vol.60 (2), p.195-198

2021

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial

European urology, 2018-06, Vol.73 (6), p.870-876

2018

Link zum Volltext

Verfügbarkeit prüfen

Changes in attitudes, practices and barriers among oncology health care professionals regarding sexual health care: Outcomes from a 2-year educational intervention at a University Hospital

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2016-04, Vol.21, p.24-30

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3307: BRCA1 promoter methylation analyzed in 1032 primary breast cancers predicts favorable response to chemotherapy independently of p53 mutations

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3307-3307

2018

Link zum Volltext

Verfügbarkeit prüfen

Adverse effect of docetaxel versus surveillance after radical prostatectomy for high risk prostate cancer: Post-hoc analysis of the prospective randomized, open-label phase III SPCG 12 trial

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.30-30

2018

Link zum Volltext

Verfügbarkeit prüfen

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden

Scientific reports, 2020-10, Vol.10 (1), p.17623-17623, Article 17623

2020

Link zum Volltext

Verfügbarkeit prüfen

Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1

Acta oncologica, 2020-07, Vol.59 (7), p.825-832

2020

Link zum Volltext

Verfügbarkeit prüfen

CARD: Overall survival (OS) analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel versus abiraterone or enzalutamide

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5569-5569

2020

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase III trial between adjuvant docetaxel and surveillance after radical prostatectomy for high risk prostate cancer: Results of SPCG12

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5001-5001

2016

Link zum Volltext

Verfügbarkeit prüfen

A common variant at 8q24.21 is associated with renal cell cancer

Nature communications, 2013, Vol.4 (1), p.2776-2776, Article 2776

2013

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

JNCI cancer spectrum, 2020-04, Vol.4 (2), p.pkz100-pkz100

2020

Link zum Volltext

Verfügbarkeit prüfen

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

Breast cancer research and treatment, 2011-08, Vol.128 (3), p.755-763

2011

Link zum Volltext

Verfügbarkeit prüfen

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers

The journal of pathology. Clinical research, 2015-01, Vol.1 (1), p.33-40

2015

Link zum Volltext

Verfügbarkeit prüfen

Radiation-induced cell cycle response in lymphocytes is not related to clinical side-effects in breast cancer patients

Anticancer research, 2003-05, Vol.23 (3C), p.3077

2003

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Cancer discovery, 2021-11, Vol.11 (11), p.2796-2811

2021

Link zum Volltext

Verfügbarkeit prüfen

A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin ) on a Named Patient Basis in Sweden

Acta oncologica, 2002, Vol.41 (3), p.276-281

2002

Link zum Volltext

Verfügbarkeit prüfen

Samanburður á greiningu og meðferð ífarandi krabbameina milli Íslands og Svíþjóðar

Laeknabladid, 2020-09, Vol.106 (9), p.397-402

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Humans
(15)
Oncology
(11)
Aged
(9)
Female
(9)
Middle Aged
(9)
Male
(8)
Adult
(7)
Medicin Och Hälsovetenskap
(7)
Cancer Therapies
(5)
Metastasis
(5)
Treatment Outcome
(5)
Antineoplastic Agents - Therapeutic Use
(4)
Biological And Medical Sciences
(4)
Breast Neoplasms - Drug Therapy
(4)
Chemotherapy
(4)
Disease-Free Survival
(4)
Medical Sciences
(4)
Patients
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma

Safety of rituximab therapy during the first trimester of pregnancy: a case history

1088 DRUG-INDUCED LIVER INJURY DUE TO CHEMOTHERAPEUTIC AGENTS AND OTHER CANCER MEDICATIONS. A POPULATION BASED STUDY

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Hepatotoxicity associated with ribociclib among breast cancer patients

Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial

Changes in attitudes, practices and barriers among oncology health care professionals regarding sexual health care: Outcomes from a 2-year educational intervention at a University Hospital

Abstract 3307: BRCA1 promoter methylation analyzed in 1032 primary breast cancers predicts favorable response to chemotherapy independently of p53 mutations

Adverse effect of docetaxel versus surveillance after radical prostatectomy for high risk prostate cancer: Post-hoc analysis of the prospective randomized, open-label phase III SPCG 12 trial

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden

Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1

CARD: Overall survival (OS) analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel versus abiraterone or enzalutamide

Efficacy and safety in older patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel (CBZ) versus abiraterone (ABI) or enzalutamide (ENZ) in the CARD study

Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study

A randomized phase III trial between adjuvant docetaxel and surveillance after radical prostatectomy for high risk prostate cancer: Results of SPCG12

Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study

A common variant at 8q24.21 is associated with renal cell cancer

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers

Radiation-induced cell cycle response in lymphocytes is not related to clinical side-effects in breast cancer patients

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin ) on a Named Patient Basis in Sweden

PD16-08 EFFECT OF CABAZITAXEL VS ABIRATERONE OR ENZALUTAMIDE ON PATIENT-REPORTED OUTCOMES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: A PRE-PLANNED EQ-5D-5L ANALYSIS OF THE CARD STUDY

Samanburður á greiningu og meðferð ífarandi krabbameina milli Íslands og Svíþjóðar

Suchergebnisse filtern